| 词条 | Echothiophate |
| 释义 |
| Verifiedfields = changed | verifiedrevid = 461092284 | IUPAC_name = 2-(Diethoxyphosphorylsulfanyl)ethyl-N,N,N-trimethylazanium iodide | image = Echothiophate iodide.svg | width = 170px | image2 = Echothiophate-Molecule-3D-balls.png | width2 = 200px | tradename = Phospholine | pregnancy_category = | legal_status = | routes_of_administration = Topical (eye drops) | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | CAS_number_Ref = {{cascite|correct|??}} | CAS_number = 6736-03-4 | ATC_prefix = S01 | ATC_suffix = EB03 | ATC_supplemental = | PubChem = 10547 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = DB01057 | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID = 10107 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = 0F350BVT6S | KEGG_Ref = {{keggcite|correct|kegg}} | KEGG = D02193 | ChEBI_Ref = {{ebicite|correct|EBI}} | ChEBI = 59849 | ChEMBL_Ref = {{ebicite|changed|EBI}} | ChEMBL = 1201341 | C=9 | H=23 | I=1 | N=1 | O=3 | P=1 | S=1 | molecular_weight = 383.228 g/mol | smiles = [I-].O=P(OCC)(OCC)SCC[N+](C)(C)C | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C9H23NO3PS.HI/c1-6-12-14(11,13-7-2)15-9-8-10(3,4)5;/h6-9H2,1-5H3;1H/q+1;/p-1 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = OVXQHPWHMXOFRD-UHFFFAOYSA-M }}Echothiophate (Phospholine) is an irreversible acetylcholinesterase inhibitor.[1] UsesIt is used as an ocular antihypertensive in the treatment of chronic glaucoma and, in some cases, accommodative esotropia. It is available under several trade names such as Phospholine Iodide (Wyeth-Ayerst). Echothiophate binds irreversibly to cholinesterase. Because of the very slow rate at which echothiophate is hydrolyzed by cholinesterase, its effects can last a week or more. Adverse effects include muscle spasm and other systemic effects. Mechanism of actionIt covalently binds by its phosphate group to serine group at the active site of the cholinesterase. Once bound, the enzyme is permanently inactive and the cell has to make new enzymes. ShortageWyeth Pharmaceuticals stopped manufacturing echothiophate iodide in the US in 2003. After contacting the American Academy of Ophthalmology (AAO), Wyeth rescinded their decision and, according to AAO public relations representative Michelle Stephens, the AAO and Wyeth were in talks for about a year about manufacturing it.[2] In the meantime, a worldwide shortage of the drug has occurred. ChemistryEchothiophate is made by reacting diethylchlorophosphoric acid with 2-dimethylaminoethylmercaptan, giving S-(2-dimethylaminoethyl)-O,O-diethylthiophosphate, which is alkylated by methyl iodide, forming echothiophate.[3] References1. ^{{cite journal |vauthors=Gabelt BT, Hennes EA, Seeman JL, Tian B, Kaufman PL |title=H-7 effect on outflow facility after trabecular obstruction following long-term echothiophate treatment in monkeys |journal=Invest. Ophthalmol. Vis. Sci. |volume=45 |issue=8 |pages=2732–6 |date=August 2004 |pmid=15277498 |doi=10.1167/iovs.04-0083 |url=http://www.iovs.org/cgi/pmidlookup?view=long&pmid=15277498}} {{Opthalmologicals}}{{Acetylcholine metabolism and transport modulators}}2. ^Eurotimes article: "Echothiophate iodide shortage leaves US specialists struggling to find alternative for acute cases" 3. ^H.M. Fitch, {{US Patent|2911430}} (1959) 6 : Acetylcholinesterase inhibitors|Phosphorothioates|Ophthalmology drugs|Quaternary ammonium compounds|Iodides|Thiocholine esters |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。